 |
|
Prognostic Groups of Patients With Stage I Melanoma
Christa Kuehnl-Petzoldt, MD;
Hans Wiebelt, PhD;
Hermann Berger, MD
Arch Dermatol. 1983;119(10):816-819.
Abstract
• The thickness of melanomas, presence or absence of ulceration, and the sex of the patient were the three dominant variables affecting the eight-year survival of 1,191 patients with clinical stage I melanoma in the prospective German melanoma group. With regard to these variables, three prognostic groups were defined representing 30%, 9%, and 61% of the patients, respectively. The good prognosis group (93% of patients surviving eight years) consisted of women with melanomas that were 1.5 mm thick or less. The intermediate prognosis group (78% of patients surviving eight years) consisted of men with nonulcerated melanomas that were 1.5 mm thick or less. The poor prognosis group (46% of patients surviving eight years) consisted of all who were left with remaining melanomas, ie, all those with melanomas thicker than 1.5 mm, and in men ulcerated tumors that were 1.5 mm thick or less.
(Arch Dermatol 1983;119:816-819)
Author Affiliations
From the Universitäts-Hautklinik Göttingen (Drs Kuehnl-Petzoldt and Berger), Freiburg, Germany; and Institut für Medizinische Dokumentation, Information und Statistik am Deutschen Krebsforschuntgszentrum, Heidelberg, Germany (Dr Wiebelt).
Footnotes
Accepted for publication Dec 15, 1982.
Read in part before the Third European Workshop on Melanin Pigmentation, Prague, Sept 30, 1981.
Reprint requests to Rosa strasse 9, D-7800, Freiburg, Federal Republic of Germany (Dr Kuehnl-Petzoldt).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Balch et al.
JCO 2001;19:3622-3634.
ABSTRACT
| FULL TEXT
|
